Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

2,809 total articles

UiPath: Cash Cushion, Solid FCF and AI Momentum Make This a Tactical Buy

UiPath: Cash Cushion, Solid FCF and AI Momentum Make This a Tactical Buy

UiPath (PATH) trades at roughly a $5.9B market cap with an enterprise value near $5.0B, about $960M in reported cash and $352M in annual free cash flow. Management is pivoting into agentic AI orchestration and recent product partnerships add credibility. With valuation stretched toward the cheap side of AI peers (P/S ~3.66, P/E ~20.9) and a tidy ba…

Caterpillar: Betting on the Gigawatt Pivot - An Actionable Mid-Term Long

Caterpillar: Betting on the Gigawatt Pivot - An Actionable Mid-Term Long

Caterpillar is more than construction equipment. Recent commercial tie-ups around behind-the-meter generation and a reopening of infrastructure demand make CAT a compelling mid-term long. Valuation is rich by historical cyclicals standards, but orders-for-power and services durability support upside. Trade plan included: entry $710.00, stop $675.00…

TRX Gold: Self-Funding Growth at a Discount to the Gold Story

TRX Gold: Self-Funding Growth at a Discount to the Gold Story

TRX Gold (TRX) is a mid-tier Tanzania-focused producer showing rapid revenue and EBITDA growth, funded by operations and brownfield expansion rather than equity dilution. With fiscal 2025 revenue of $57.6M and EBITDA of $22M, a planned throughput increase and gold at multi-year highs, TRX offers an asymmetric risk-reward for a long trade. Entry $1.…

SoFi: Short-Seller Shock Crafted a High-Conviction Buy Zone

SoFi: Short-Seller Shock Crafted a High-Conviction Buy Zone

SoFi plunged on a short-seller report that critics call sensationalist. Fundamentals still show rapid user growth, an improving profitability profile and a market cap of ~$20.2B that feels priced for disappointment. This trade idea lays out an entry at $15.50, a stop at $13.75 and a first target of $22.00 over a mid-term recovery window.

Road Repricing Is Too Harsh - Upgrade to Buy for a Mid-Term Bounce

Road Repricing Is Too Harsh - Upgrade to Buy for a Mid-Term Bounce

Construction Partners (ROAD) just sold off sharply, pushing valuation metrics back toward reason while fundamentals and cash flow remain intact. We upgrade to BUY with a defined entry at $105.88, a stop at $98.00 and a target at $132.00 for a mid-term trade (45 trading days). The setup leans on strong FCF, manageable leverage relative to cash gener…

Nano Labs: Deep-Value Chip Play with a Crypto Hinge

Nano Labs: Deep-Value Chip Play with a Crypto Hinge

Nano Labs (NA) trades near multi-month lows at $2.97 with a market cap of $70.0M, a P/E of 3.71 and P/B of 0.64. The company has pivoted to accumulate crypto reserves (notably BNB), slashed operating costs, and continues to ship edge AI / HPC silicon. That combination makes NA a high-risk, high-reward swing trade: undervalued on headline multiples …

Box: Cash Flow Strength Says Buy - Valuation Still Too Cheap Near $24

Box: Cash Flow Strength Says Buy - Valuation Still Too Cheap Near $24

Box has shifted from pure cloud storage to an AI-enabled content platform, and its cash flow profile today argues for a higher multiple than the market is assigning. At ~$24, the stock trades at an attractive EV/FCF (~9.7) and an implied FCF yield north of 10%. This trade targets a re-rating to a more rational multiple as enterprise adoption of Box…

Buy GXO on Contract Wins and Network Leverage, But Respect Macro Drag

Buy GXO on Contract Wins and Network Leverage, But Respect Macro Drag

GXO Logistics is a buy here for traders willing to own a market-leading contract logistics operator while event risk and macro softness remain elevated. The company's recent contract expansions, strategic defence and healthcare wins, and relatively low price-to-sales multiple argue for upside toward $66. A measured entry at $53.00 with a $48 stop b…